Resultados de procura - V. Subbiah
- Mostrando 1 - 3 Resultados de 3
-
1
First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors por Siqing Fu, Hal W. Hirte, Stephen Welch, T. Toney Ilenchuk, Tyler Lutes, Christopher Rice, Nigel Fields, Agnes Nemet, Dominique Dugourd, Sarina A. Piha‐Paul, V. Subbiah, L. Liu, Jing Gong, David S. Hong, John M. Stewart
Publicado 2017Artigo -
2
LBA12 Efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients (pts) with an FGFR2-fusion or rearrangement (f/r), FGFR inhibitor (FGFRi)-naïve cholangiocarcinoma (CCA):... por A. Hollebecque, Mitesh J. Borad, Lipika Goyal, A. Schram, J.O. Park, P.A. Cassier, Suneel D. Kamath, D.T. Wai Meng, E. Dotan, R. Kim, V. Sahai, D-Y. Oh, C-Y. Liao, M. Millward, D. Roda Perez, C. Ferté, R. Blakesley, B. Wolf, V. Subbiah, R.K. Kelley
Publicado 2022Artigo -
3
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice por C. Benedikt Westphalen, L. Boscolo Bielo, Philippe Aftimos, Himisha Beltran, Manuela Benary, Debyani Chakravarty, Maike Collienne, Rodrigo Dienstmann, Aisha Helali, Justin F. Gainor, Peter Horak, C. Le Tourneau, Caterina Marchiò, Christophe Massard, Funda Meric‐Bernstam, Chantal Pauli, G. Pruneri, Felipe Roitberg, Hege G. Russnes, David B. Solit, Naureen Starling, V. Subbiah, David Tamborero, Noelia Tarazona, Clare Turnbull, Joris van de Haar, Fabrice André, Joaquı́n Mateo, Giuseppe Curigliano
Publicado 2025Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Pharmacology
Adverse effect
Anemia
Asymptomatic
Cancer
Clinical Oncology
Clinical Practice
Common Terminology Criteria for Adverse Events
Epistemology
Family medicine
Gastroenterology
Hypokalemia
Hypophosphatemia
Medical physics
Neutropenia
Oncology
Pharmacodynamics
Pharmacokinetics
Phases of clinical research
Philosophy
Precision oncology
Quality (philosophy)
Response Evaluation Criteria in Solid Tumors
Tolerability
Toxicity